[
    {
        "data": {
            "description": "Survey of the drug development process from target identification, development, preclinical studies, clinical trials to post-approval monitoring, particularly as applicable to neuroactive drugs. Differences between small and large molecules (biologics) will be covered, along with a basic coverage of regulatory authorities. A brief history of drug development will be provided, along with coverage of special topics related to stages of the drug development process. Broad survey-style overview of the phases in the drug development process, regulatory considerations, relevant vocabulary, and the ability to communicate within the industry.",
            "id": "PHMSCI 757",
            "parent": "PHMSCI",
            "title": "SURVEY OF THE NEUROACTIVE DRUG DEVELOPMENT PROCESS"
        }
    },
    {
        "data": {
            "id": "PHMSCI",
            "type": "compound"
        }
    }
]